Page last updated: 2024-08-24

aripiprazole and Mood Disorders

aripiprazole has been researched along with Mood Disorders in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (45.83)29.6817
2010's12 (50.00)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
DelBello, MP; Jallaq, SA; Martin, LJ; Ramsey, LB; Strawn, JR; Verba, M1
Binici, NC; Güney, SA1
Bota, RG; Hazen, J; Howard, P; Nguyen, C; Novac, A; Tieu, R1
Gunes, S1
Bartram, LA; Coury, DL; Lozano, J1
Camkurt, MA; Gunes, S; Tecimer, E1
Jing, Y; Kim, E; Pikalov, A; Tran, QV; You, M1
Bengtson, M; Edge, PJ; Murphy, TK; Mutch, PJ; Reid, JM; Storch, EA; Yang, M1
Agüera-Ortiz, L; Hurtado de Mendoza, A; Osorio, RS; Palomo, T; Ramos, I1
Wagner, KD1
McIntyre, RS2
Aleman, A; Bous, J; Hollander, K; Knegtering, H; Liemburg, E1
Kurokawa, K; Ohkuma, S; Shibasaki, M1
Ahn, ES; Pidcock, FS; Sanz, JH; Slomine, BS; Wachtel, LE; Yap, JL1
Coffey, DB; John, N; Potter, PO1
Sajatovic, M1
Buckley, PF1
Demb, H; Valicenti-McDermott, MR1
García-Amador, M; Goikolea, JM; Pacchiarotti, I; Sanchez, RF; Valentí, M; Vieta, E1
Modestin, J; Schneiter, R; Traber, R1
Rai, A; Spiegel, D; Urbano, M1
Carlson, BX; Eudicone, J; Frye, MA; Marcus, RN; McQuade, RD; Pikalov, A1
Stahl, SM1

Reviews

5 review(s) available for aripiprazole and Mood Disorders

ArticleYear
Aripiprazole for treating irritability associated with autism spectrum disorders.
    Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:12

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Communication; Humans; Irritable Mood; Mood Disorders; Treatment Outcome

2019
[Functional homology between alcohol dependence and mood disorder].
    Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence, 2011, Volume: 46, Issue:3

    Topics: Alcoholism; Animals; Antipsychotic Agents; Aripiprazole; Hypothalamo-Hypophyseal System; Mice; Mood Disorders; Piperazines; Pituitary-Adrenal System; Quinolones; Receptors, Serotonin; Serotonin Plasma Membrane Transport Proteins

2011
Treatment for mood and anxiety disorders: quetiapine and aripiprazole.
    Current psychiatry reports, 2003, Volume: 5, Issue:4

    Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Dibenzothiazepines; Humans; Mood Disorders; Piperazines; Quetiapine Fumarate; Quinolones

2003
Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole.
    Drugs of today (Barcelona, Spain : 1998), 2005, Volume: 41, Issue:1

    Topics: Antipsychotic Agents; Aripiprazole; Humans; Mood Disorders; Piperazines; Quinolones; Schizophrenia

2005
Role of aripiprazole in treating mood disorders.
    Expert review of neurotherapeutics, 2006, Volume: 6, Issue:12

    Topics: Administration, Oral; Antipsychotic Agents; Aripiprazole; Clinical Trials as Topic; Drug Administration Schedule; Humans; Mood Disorders; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinolones; Treatment Outcome

2006

Trials

2 trial(s) available for aripiprazole and Mood Disorders

ArticleYear
Open label aripiprazole in the treatment of youth with tic disorders.
    Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:4

    Topics: Adolescent; Age Factors; Aripiprazole; Child; Female; Humans; Male; Mood Disorders; Piperazines; Quinolones; Tic Disorders; Treatment Outcome

2009
An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being.
    Pharmacopsychiatry, 2011, Volume: 44, Issue:3

    Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Mood Disorders; Personal Satisfaction; Pilot Projects; Piperazines; Pleasure; Quinolones; Risperidone; Schizophrenia

2011

Other Studies

17 other study(ies) available for aripiprazole and Mood Disorders

ArticleYear
CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders.
    Journal of child and adolescent psychopharmacology, 2021, Volume: 31, Issue:1

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Male; Mood Disorders; Pharmacogenetics; Phenotype; Retrospective Studies

2021
Epistaxis as an Unexpected Side Effect of Aripiprazole and Risperidone Treatment in Two Children with Two Different Psychiatric Diagnosis.
    Journal of child and adolescent psychopharmacology, 2017, Volume: 27, Issue:8

    Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Epistaxis; Humans; Male; Mood Disorders; Risperidone

2017
Weight gain changes in patients with aripiprazole monotherapy compared with aripiprazole-antidepressant polypharmacy in an outpatient sample.
    Journal of psychopharmacology (Oxford, England), 2018, Volume: 32, Issue:4

    Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Body Mass Index; Cohort Studies; Depression; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Outpatients; Polypharmacy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Weight Gain

2018
Hyperprolactinemic Galactorrhea as a Side Effect of Aripiprazole: An Adolescent Case (Aripiprazole-Related Hyperprolactinemic Galactorrhea).
    Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:2

    Topics: Adolescent; Adolescent Behavior; Antipsychotic Agents; Aripiprazole; Female; Galactorrhea; Humans; Hyperprolactinemia; Mood Disorders

2018
Aripiprazole-Induced Raynaud's Phenomenon: An Adolescent Case.
    Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:10

    Topics: Adolescent; Aripiprazole; Humans; Male; Mood Disorders; Raynaud Disease

2016
Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Journal of medical economics, 2009, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Costs and Cost Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Middle Aged; Mood Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome; Young Adult

2009
Treatment of tardive dyskinesia with aripiprazole.
    Neurotoxicity research, 2010, Volume: 17, Issue:4

    Topics: Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Male; Mood Disorders; Piperazines; Quinolones

2010
Life events, medical comorbidity, and somatic symptoms in pediatric mood disorders.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:10

    Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Comorbidity; Female; Humans; Hungary; Life Change Events; Male; Mood Disorders; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Somatoform Disorders; United States

2009
The role of aripiprazole in Canada: A review of clinical and drug discontinuation data. Foreword.
    Clinical therapeutics, 2010, Volume: 32 Suppl 1

    Topics: Antipsychotic Agents; Aripiprazole; Canada; Clinical Trials as Topic; Comorbidity; Drug Utilization; Drug Utilization Review; Humans; Metabolic Diseases; Mood Disorders; Piperazines; Psychotic Disorders; Quinolones; Risk Factors

2010
Aripiprazole: striving towards euthymia with a novel mechanism of action.
    Journal of affective disorders, 2011, Volume: 128 Suppl 1

    Topics: Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Humans; Mood Disorders; Piperazines; Quinolones

2011
Treatment of cerebellar cognitive affective syndrome with aripiprazole.
    Journal of pediatric rehabilitation medicine, 2012, Volume: 5, Issue:3

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Cerebellar Diseases; Cognition Disorders; Female; Humans; Infratentorial Neoplasms; Mood Disorders; Neurosurgical Procedures; Papilloma, Choroid Plexus; Piperazines; Postoperative Complications; Quinolones; Syndrome

2012
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.
    Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:5

    Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment

2012
Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:5

    Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Body Mass Index; Child; Child Behavior Disorders; Child, Preschool; Dose-Response Relationship, Drug; Drug Approval; Female; Follow-Up Studies; Humans; Impulsive Behavior; Intellectual Disability; Male; Mood Disorders; Piperazines; Quinolones; Reactive Attachment Disorder; Self-Injurious Behavior; Sleep Wake Disorders

2006
A case of aripiprazole-induced mania.
    Pharmacopsychiatry, 2007, Volume: 40, Issue:1

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dibenzothiazepines; Humans; Male; Mood Disorders; Piperazines; Quetiapine Fumarate; Quinolones; Schizophrenia, Paranoid

2007
Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:6

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Mood Disorders; Piperazines; Quinolones; Risperidone; Withholding Treatment

2007
Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2

    Topics: Affective Symptoms; Aggression; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Conduct Disorder; Double-Blind Method; Humans; Irritable Mood; Mood Disorders; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome

2008
Do dopamine partial agonists have partial efficacy as antipsychotics?
    CNS spectrums, 2008, Volume: 13, Issue:4

    Topics: Antipsychotic Agents; Aripiprazole; Brain; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Mood Disorders; Piperazines; Psychotic Disorders; Quinolones; Receptors, Dopamine D2; Treatment Outcome

2008